Obesity and Maternal-Placental-Fetal Immunology and Health

Meredith Monaco-Brown1, David A Lawrence2,3

  • 1Department of Pediatrics, Bernard and Millie Duker Children's Hospital at Albany Medical Center, Albany, NY, United States.

Insights

Maternal obesity and environmental chemicals disrupt placental immunology, impacting pregnancy outcomes and infant health. This review explores these immune alterations and their links to various neonatal and maternal conditions.

Area of Science:

  • Reproductive immunology
  • Environmental health
  • Perinatal medicine

Background:

  • Rising obesity rates in women of childbearing age (29%) are linked to oxidative stress and inflammation.
  • Maternal obesity is associated with placental dysfunction, leading to adverse birth outcomes like large for gestational age (LGA) infants and increased neonatal metabolic disease.
  • Environmental exposures to endocrine-disrupting and persistent chemicals exacerbate obesity and negatively affect maternal physiology, placental function, and fetal development.

Purpose of the Study:

  • To review the scientific literature on how maternal obesity and environmental chemical exposures alter maternal, placental, and fetal immunology.
  • To examine the intricate relationship between placental immune function and clinical outcomes, including neonatal conditions and maternal health.

Main Methods:

  • Systematic review of existing literature on maternal obesity, environmental chemicals, and placental immunology.
  • Analysis of studies investigating placental immune cells (e.g., macrophages, NK cells) and inflammatory mediators (cytokines).

Main Results:

  • Maternal obesity and environmental chemicals significantly alter placental immune cell populations and cytokine profiles.
  • These immunological changes are associated with adverse pregnancy outcomes such as preeclampsia, preterm birth, and fetal growth restrictions.
  • Placental immune dysregulation is linked to a spectrum of neonatal and post-natal conditions, including allergies, metabolic disorders, and neurodevelopmental issues.

Conclusions:

  • Maternal obesity and environmental exposures represent critical modulators of placental immunology.
  • Understanding these immunomodulatory effects is crucial for improving pregnancy outcomes and addressing long-term infant and maternal health challenges.
  • Further research into placental immune function can inform targeted interventions for high-risk pregnancies.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
645
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.0K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
467
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
72